Form 8-K - Current report:
SEC Accession No. 0001140361-25-000073
Filing Date
2025-01-02
Accepted
2025-01-02 16:06:06
Documents
13
Period of Report
2024-12-30
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20040947_8k.htm   iXBRL 8-K 29987
  Complete submission text file 0001140361-25-000073.txt   165125

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA adma-20241230.xsd EX-101.SCH 3998
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE adma-20241230_lab.xml EX-101.LAB 21967
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE adma-20241230_pre.xml EX-101.PRE 16055
15 EXTRACTED XBRL INSTANCE DOCUMENT ef20040947_8k_htm.xml XML 4030
Mailing Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446
Business Address C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY NJ 07446 (201) 478-5552
ADMA BIOLOGICS, INC. (Filer) CIK: 0001368514 (see all company filings)

EIN.: 562590442 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36728 | Film No.: 25502042
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)